Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leptin therapy effects on hypothalamic structure and function in congenital lipodystrophy
NL-OMON32723Not yet recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Oct 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of leptin in congenital generalized lipodystrophy (CGL), sponsored by Leiden University Medical Center. Primary endpoints: Hypothalamic BOLD signal and Hypothalamic structure. Planned start Oct 2008; status: not yet recruiting.
02
Drugs
leptin
03
Conditions
congenital generalized lipodystrophy (CGL)
Beyond the preview
Go deeper on NL-OMON32723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32723.